![Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis | Pharmacological Reviews Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/57/2/163/F1.large.jpg)
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis | Pharmacological Reviews
![Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study - Journal of the American Academy of Dermatology Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3247a83d-2f13-4521-b9c8-529cca02f340/fx1.jpg)
Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study - Journal of the American Academy of Dermatology
![Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin | The Journal of Immunology Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/200/6/2038/F1.large.jpg)
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin | The Journal of Immunology
![Lucas Morin on Twitter: "Finally some reliable data on the adverse effects of low-dose methotrexate. Large #RCT (n=4786), with median dose 15mg/week. Clinical adverse effects are substantial, but let's keep in mind Lucas Morin on Twitter: "Finally some reliable data on the adverse effects of low-dose methotrexate. Large #RCT (n=4786), with median dose 15mg/week. Clinical adverse effects are substantial, but let's keep in mind](https://pbs.twimg.com/media/ERFmFqmXsAExANR.jpg:large)
Lucas Morin on Twitter: "Finally some reliable data on the adverse effects of low-dose methotrexate. Large #RCT (n=4786), with median dose 15mg/week. Clinical adverse effects are substantial, but let's keep in mind
![Low-Dose Methotrexate Associated With Increased Risk for Certain Adverse Events - Rheumatology Advisor Low-Dose Methotrexate Associated With Increased Risk for Certain Adverse Events - Rheumatology Advisor](https://www.rheumatologyadvisor.com/wp-content/uploads/sites/18/2019/01/methotrexateg458672965_1396166.jpg)
Low-Dose Methotrexate Associated With Increased Risk for Certain Adverse Events - Rheumatology Advisor
![Dosing of methotrexate for various indications, grouped by low dose... | Download Scientific Diagram Dosing of methotrexate for various indications, grouped by low dose... | Download Scientific Diagram](https://www.researchgate.net/publication/331557812/figure/fig1/AS:814654204940291@1571240106568/Dosing-of-methotrexate-for-various-indications-grouped-by-low-dose-versus-high-dose-and.png)
Dosing of methotrexate for various indications, grouped by low dose... | Download Scientific Diagram
![SciELO - Brasil - Oral events related to low-dose methotrexate in rheumatoid arthritis patients Oral events related to low-dose methotrexate in rheumatoid arthritis patients SciELO - Brasil - Oral events related to low-dose methotrexate in rheumatoid arthritis patients Oral events related to low-dose methotrexate in rheumatoid arthritis patients](https://minio.scielo.br/documentstore/1807-3107/5MGfpQcJLZWzRV8CscBKWvJ/eea2a5c5b0bd51a4e404e1ffe0736f77dd7c378d.gif)
SciELO - Brasil - Oral events related to low-dose methotrexate in rheumatoid arthritis patients Oral events related to low-dose methotrexate in rheumatoid arthritis patients
Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases | PLOS ONE
![Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis | Pharmacological Reviews Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/57/2/163/F2.large.jpg)
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis | Pharmacological Reviews
![Transient Low-Dose Methotrexate Generates B Regulatory Cells That Mediate Antigen-Specific Tolerance to Alglucosidase Alfa | The Journal of Immunology Transient Low-Dose Methotrexate Generates B Regulatory Cells That Mediate Antigen-Specific Tolerance to Alglucosidase Alfa | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/193/8/3947/F9.large.jpg)
Transient Low-Dose Methotrexate Generates B Regulatory Cells That Mediate Antigen-Specific Tolerance to Alglucosidase Alfa | The Journal of Immunology
![Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid - Journal of the American Academy of Dermatology Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005261779/2022456738/gr1.jpg)
Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid - Journal of the American Academy of Dermatology
![Low-dose Methotrexate patient's action plan | Psoriatic Arthritis (PsA) support program | Arthritis Australia Low-dose Methotrexate patient's action plan | Psoriatic Arthritis (PsA) support program | Arthritis Australia](https://www.mypsoriaticarthritis.org.au/sites/default/files/inline-images/0001_0.jpg)
Low-dose Methotrexate patient's action plan | Psoriatic Arthritis (PsA) support program | Arthritis Australia
![Adverse Effects of Low Dose Methotrexate: Adjudicated Hematologic Outcomes in a Large Randomized Double-blind Placebo-controlled Trial - ACR Meeting Abstracts Adverse Effects of Low Dose Methotrexate: Adjudicated Hematologic Outcomes in a Large Randomized Double-blind Placebo-controlled Trial - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2020/09/OCMVWLVW-906756-1-ANY.jpg)
Adverse Effects of Low Dose Methotrexate: Adjudicated Hematologic Outcomes in a Large Randomized Double-blind Placebo-controlled Trial - ACR Meeting Abstracts
![Frontiers | Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis Frontiers | Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis](https://www.frontiersin.org/files/MyHome%20Article%20Library/643459/643459_Thumb_400.jpg)
Frontiers | Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
![SAT0153 Effectiveness of low and high dose methotrexate in combination with adalimumab in a real world setting: results from the corrona rheumatoid arthritis registry | Annals of the Rheumatic Diseases SAT0153 Effectiveness of low and high dose methotrexate in combination with adalimumab in a real world setting: results from the corrona rheumatoid arthritis registry | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/76/Suppl_2/827.2/F1.large.jpg)